SAN FRANCISCO, Jan. 26, 2021 /PRNewswire/ -- Invitae
Corporation (NYSE: NVTA) today announced the closing of its
underwritten public offering of 8,932,038 shares of its common
stock, including 1,165,048 shares sold pursuant to the exercise in
full of the underwriters' option to purchase additional shares, at
the public offering price of $51.50
per share. As a result of the underwriters' option exercise, the
aggregate gross proceeds to Invitae from the offering, before
deducting underwriting discounts and commissions and other offering
expenses, was approximately $460.0 million.
J.P. Morgan Securities LLC, Morgan Stanley, Cowen and Company,
LLC and SVB Leerink LLC acted as the book-running
managers for the offering. William Blair &
Company, L.L.C. acted as co-manager for the offering.
An automatic shelf registration statement relating to the shares
was filed with the Securities and Exchange Commission and became
effective on March 4, 2019. A copy of
the final prospectus supplement and accompanying prospectus
relating to the offering may be obtained from J.P. Morgan
Securities LLC, c/o Broadridge Financial Solutions, 1155 Long
Island Avenue, Edgewood, NY 11717,
by telephone at (866) 803-9204, or by email at
prospectus-eq_fi@jpmchase.com; from Morgan Stanley & Co. LLC,
180 Varick Street, 2nd Floor, New York,
NY, 10014, Attention: Prospectus Department; from Cowen and
Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, Attn:
Prospectus Department, by email at
PostSaleManualRequests@broadridge.com, or by telephone at (833)
297-2926; or from SVB Leerink LLC, One Federal Street, 37th Floor,
Boston, MA 02110, Attention:
Syndicate Department, by telephone at (800) 808-7535, ext. 6132, or
by email at syndicate@svbleerink.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About Invitae Corporation
Invitae Corporation (NYSE: NVTA) is a leading medical genetics
company whose mission is to bring comprehensive genetic information
into mainstream medicine to improve healthcare for billions of
people. Invitae's goal is to aggregate the world's genetic tests
into a single service with higher quality, faster turnaround time,
and lower prices.
Contact:
Laura D'Angelo
ir@invitae.com
(628) 213-3369
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invitae-announces-exercise-in-full-of-underwriters-option-to-purchase-additional-shares-of-common-stock-and-closing-of-underwritten-public-offering-301215534.html
SOURCE Invitae Corporation